An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Egaten

Chemical Nametriclabendazole
Dosage FormTablet (oral; 250 mg)
Drug ClassAnthelmintics
SystemDigestive
CompanyNovartis
Approval Year2019

Indication

  • For the treatment of fascioliasis in patients 6 years of age and older.
Last updated on 4/23/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Egaten (triclabendazole) Prescribing Information. 2019Novartis Pharmaceuticals Corporation, East Hanover, NJ
Document TitleYearSource
Efficacy and tolerability of two single-day regimens of triclabendazole for fascioliasis in Peruvian children. 2015Revista da Sociedade Brasileira de Medicina Tropical